Neogenomics (NEO) Change in Acquisitions & Divestments (2020 - 2025)

Neogenomics has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $9.0 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 23.58% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.0 million (down 71.34% YoY), and the FY2025 full-year result was $20.1 million, down 62.79% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $9.0 million, up from $3.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $40.4 million in Q1 2023, with the low at $3.0 million in Q2 2025.
• Historically, Change in Acquisitions & Divestments has averaged $19.3 million across 5 years, with a median of $20.1 million in 2024.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments jumped 673.94% — and 2025, when it plunged 85.29%.
• Neogenomics' Change in Acquisitions & Divestments stood at $18.2 million in 2021, then surged by 48.64% to $27.1 million in 2022, then slipped by 10.52% to $24.3 million in 2023, then sank by 74.72% to $6.1 million in 2024, then jumped by 46.77% to $9.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $9.0 million (Q3 2025), $3.0 million (Q2 2025), and $8.1 million (Q1 2025), per Business Quant data.